Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 49, pseudogene (RNU6-49P) is a pseudogene related to the U6 small nuclear RNA family of genes, which normally play an essential role in splicing nuclear pre-mRNAs as core components of the spliceosome[2][3]. As a pseudogene, RNU6-49P is not believed to produce a functional RNA or protein product; its sequence is similar to that of U6 small nuclear RNA but does not participate in splicing or other cellular functions[2]. Pseudogenes are generally considered non-functional genomic elements derived from ancestral functional genes or RNAs, often resulting from gene duplication or retrotransposition events, but lacking the necessary regulatory elements or sequence integrity to be biologically active[2][1]. RNU6-49P is not considered a therapeutic target, nor does it serve as a disease biomarker or interact with drugs[2]. Its designation as a pseudogene means it is of minimal direct clinical or therapeutic relevance. The entry is potentially misleading as a therapeutic target because pseudogenes, by definition, are generally not functional targets unless new evidence of regulatory roles emerges, which is not the case here[2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 49, pseudogene (RNU6-49P).